Dexamethasone Dosage for Nausea and Vomiting in Chemotherapy
Author Information
Author(s): Münstedt K, Müller H, Blauth-Eckmeyer E, Stenger K, Zygmunt M, Vahrson H
Primary Institution: Justus-Liebig-University Giessen
Hypothesis
Does the dosage of dexamethasone in combination with 5-HT3 antagonists affect the control of chemotherapy-induced nausea and vomiting?
Conclusion
Higher doses of dexamethasone do not provide better control of nausea and vomiting compared to lower doses.
Supporting Evidence
- High-dose dexamethasone (20 mg) had no advantage over medium-dose dexamethasone.
- Lower doses of dexamethasone appear more beneficial for controlling nausea and vomiting.
Takeaway
This study looked at how much dexamethasone to use with other medicines to help stop nausea from chemotherapy, and found that using less might be just as good.
Methodology
A prospective, single-blind, randomized trial comparing 8 mg and 20 mg doses of dexamethasone with tropisetron in patients undergoing cis-platinum-containing chemotherapy.
Limitations
The study was limited to an interim analysis and may not reflect long-term outcomes.
Participant Demographics
Patients undergoing cis-platinum-containing chemotherapy.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website